Immune response after striatal engraftment of fetal neuronal cells in patients with Huntington's disease: Consequences for cerebral transplantation programs

Clinical and Experimental Neuroimmunology

Volumn 2, Issue 2, 2011, Pages 25-32

  Krebs, Simone S ^a   Trippel, Michael ^a   Prokop, Thomas ^a   Omer, Talib N ^a   Landwehrmeyer, Bernard ^b   Weber, Wolfgang A ^a   Nikkhah, Guido ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

brain's immune response; cerebral engraftment; Huntington's disease

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; FLUORODEOXYGLUCOSE F 18; HLA ANTIBODY; METHYLPREDNISOLONE;

ADULT; ALLOTRANSPLANTATION; ARTICLE; CELL TRANSPLANTATION; CLINICAL ARTICLE; DRUG WITHDRAWAL; ENGRAFTMENT; FEMALE; FETUS; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MALE; NEURONAL TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 80051698461     PISSN: None     EISSN: 17591961     Source Type: Journal    
DOI: 10.1111/j.1759-1961.2011.00018.x     Document Type: Article

References (27)

1. Rosser AE, Barker RA, Harrower T, Watts C, Farrington M, Ho A, et al., Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease. J Neurol Neurosurg Psychiatry. 2002; 73: 678-85. (Pubitemid 35448852)
2. Hauser RA, Furtado S, Cimino CR, et al., Bilateral human fetal striatal transplantation in Huntington's disease. Neurology. 2002; 58: 687-95. (Pubitemid 34211545)
3. Bachoud-Lévi A, Bourdet C, Brugières P, et al., Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp Neurol. 2000; 161: 194-202. (Pubitemid 30136541)
4. Bachoud-Lévi AC, Rèmy P, Nguyen JP, et al., Motor and cognitive improvement in patients with Huntington's disease after neural transplantation. Lancet. 2000; 356: 1975-9.
5. Bradley JA, Bolton EM, Pedersen RA,. Stem cell medicine encounters the immune system. Nat Rev Immunol. 2002; 2: 859-71. (Pubitemid 37328708)
6. Barker RA, Widner H,. Immune problems in central nervous system cell therapy. NeuroRx. 2004; 1: 472-81. (Pubitemid 46613779)
7. Brandis A, Kuder H, Knappe U, et al., Time-dependent expression of donor- and host-specific major histocompatibility complex class I and II antigens in allogeneic dopamine-rich macro- and micrografts: comparison of two different grafting protocols. Acta Neuropathol. 1998; 95 (1): 85-97. (Pubitemid 28075931)
8. Capetian P, Knoth R, Maciaczyk J, et al., Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation. Neuroscience. 2009; 160 (3): 661-75.
9. Krystkowiak P, Gaura V, Labalette M, et al., Alloimmunisation to donor antigens and immune rejection following fetal neural grafts to the brain in patients with Huntington's disease. PLoS ONE. 2007; 1: e166.
10. Defer GL, Geny C, Ricolfi F, et al., Long-term outcome of unilaterally transplanted parkinsonian patients. Clinical approach. Brain. 1994; 119: 41-50.
11. Bachoud-Lévi AC, Gaura V, Brugières P, et al., Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol. 2006; 5: 303-9.
12. Peschanski M, Bachoud-Levi AC, Hantraye P,. Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease. Brain. 2004; 127: 1219-28. (Pubitemid 38745503)
13. McKenna RM, Takemoto SK, Terasaki PI,. Anti-HLA antibodies after solid organ transplantation. Transplantation. 2000; 69: 319-26. (Pubitemid 30118107)
14. Fricker RA, Barker RA, Fawcett JA, et al., A comparative study of preparation techniques for improving the viabilility of striatal grafts using vital stains, in vitro cultures and in vivo grafts. Cell Transplant. 1996; 4: 173-200.
15. Hurelbrink CB, Armstrong RJ, Barker RA, et al., Hibernated human fetal striatal tissue: successful transplantation in a rat model of Huntington's disease. Cell Transplant. 2000; 9: 743-9. (Pubitemid 32102064)
16. Hurelbrink CB, Tyers P, Armstrong RJ, et al., Long-term hibernation of human fetal striatal tissue does not adversely affect its differentiation in vitro or graft survival: implications for clinical trials in Huntington's disease. Cell Transplant. 2003; 12: 687-95. (Pubitemid 37409737)
17. Widner H,. Immunological issues in rodent and primate transplants (allografts). In:, Freeman T, Widner H, eds. Cell transplantation for neurological disorders. Towards reconstruction of the human central nervous system. Totowa, NJ: Humana Press; 1998; 171-88.
18. Nikkhah G, Olsson M, Eberhard J, et al., A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience. 1994; 63: 57-72. (Pubitemid 24333952)
19. Winkler C, Kirik D, Bjorklund A,. Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci. 2005; 28: 86-92. (Pubitemid 40178925)
20. Widner H, Brundin P, Björklund A, et al., Survival and immunogenicity of dissociated allogeneic fetal neural dopamine-rich grafts when implanted into the brains of adult mice. Exp Brain Res. 1989; 76: 187-97. (Pubitemid 19167231)
21. Mendez I, Sanchez-Pernaute R, Cooper O, et al., Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain. 2005; 128 (7): 1498-510. (Pubitemid 41373670)
22. Mendez I, Viñuela A, Astradsson A, et al., Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat Med. 2008; 14: 507-9. (Pubitemid 351655215)
23. Pedersen EB, Poulsen FR, Zimmer J, et al., Prevention of mouse-rat brain xenograft rejection by a combination therapy of cyclosporine A, prednisolone and azathioprine. Exp Brain Res. 1995; 106: 181-6.
24. Newell KA, Asare A, Kirk AD, Trang D, Gisler TD, Bourcier K, Suthanthiram M, et al., Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest. 2010; 120 (6): 1836-47.
25. Nicholas MK, Antel JP, Stefansson K, Arnason BG,. Rejection of fetal neocortical neural transplants by H-2 incompatible mice. J Immunol. 1987; 139 (7): 2275-83. (Pubitemid 17152122)
26. Tambuyzer BR, Bergwer I, De Voch N, et al., Allogeneic stromal cell implantation in brain tissue leads to robust microglial activation. Immunol Cell Biol. 2009; 87: 267-73.
27. Hauser R, Freeman TB, Snow BJ, et al., Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol. 1999; 56: 179-87. (Pubitemid 29076182)